World reacts to shock development in Antarctica: ‘Oh my god!'
Social media has erupted into debate after stunning findings revealed that the Antarctic Ice Sheet had gone through record-breaking growth after decades of loss.
In what seems like music to the ears of climate sceptics who have long derided doom-and-gloom predictions, a study published in Science China Earth Sciences found that between 2021 and 2023 the Antarctic Ice Sheet (AIS) grew by an unprecedented amount.
The report says that between 2021 and 2023, the ice sheet grew by almost 108 gigatons (or 108 billion metric tons) of ice per year.
The reason for the rise is reportedly due to an unusual increase in precipitation, particularly in East Antarctica, leading to an accumulation of snow and ice.
To put it in perspective, between 2002 and 2010, the AIS lost mass at a rate of almost 74 gigatons a year, resulting in a 0.2mm per year global sea-level rise. Between 2011 and 2020, that rose to more than 142 gigatons a year, a sea-level rise of 0.39mm per year.
But the recent increase in ice has seen a 0.30mm offset between 2021-2023.
In the Wilkes Land–Queen Mary Land region of Antarctica, four major glaciers — Totten, Moscow University, Denman and Vincennes Bay — had been losing the most mass.
Cosmos reported that Vincennes Bay and Denham had suffered 'intense' losses, suffering about 72.5 per cent surface melt and 27.5 per cent ice loss according Dr Wei Wang of Shanghai's Tonji University.
But between 2021 and 2023, this area had received the most mass gain.
This is important considering those glaciers are among the most vulnerable on the continent and that Antarctica holds around half of the freshwater on Earth.
However, for those believing it may be the end of global warming, scientist warn that this may not signal a long-term trend.
Internet runs wild with finding: 'Oh my god'
Despite there being a bit more to the story, the promising headline was enough for the internet to run with the findings.
X user Collin Rugg, who has 1.8m followers on the platform, shared the news on his account, writing that it was 'crazy'.
He also included a line tempering the findings, saying: 'Scientists say much of the gains are linked to precipitation patterns, which could be temporary.'
But his comments quickly went nuts.
Self-described 'populist Republican' and founder of The Loud Majority podcast Kevin Smith replied: 'So Al Gore was wrong again??? Is climate change over?'
Canadian-American venture capitalist Chamath Palihapitiya commented: 'Oh my god! All the protests and virtue signalling worked!!!'
January 6 rioter Derrick Evans added: 'Poor Greta will have to come up with a new scam.'
Founder and Executive Director of Power The Future Daniel Turner claimed the story was proof you should 'never believe a climate alarmist'.
And this is just the tip of the metaphorical iceberg.
There were plenty more who hit out at the news, but others put it in context.
Crypto journalist Laura Shin suggested: 'Wouldn't it be because of Covid? People were flying and driving less, so emissions were down?'
Others pointed out that it was a 'temporary' and 'anomalous' precipitation accumulation and that it had been trending down for over 20 years.
Professor at the University of Ottawa Ryan Katz-Rosene, PhD also tried to put it in context, showing a graph of how the ice sheet had fared since the 1980s.
Yes, there was a record -breaking mass gain for the Antarctic ice sheet from 2021 to 2023, thanks to increased precipitation in East Antarctica. This is what it looks like in contextðŸ'‡
(h/t @Marcusgibson) pic.twitter.com/KCw3RNar49
— Ryan Katz-Rosene, PhD (@ryankatzrosene) May 5, 2025
Two-thirds of the world's freshwater is held between Antarctica and Greenland, with NASA finding that Greenland is declining at twice the rate of Antarctica — and there was no bounce back Greenland, which has been losing ice at a reasonably steady rate since 2002.
This data is from NASA's GRACE (Gravity Recovery and Climate Experiment) mission — which ended in June 2017 — and GRACE Follow-On mission — which began in June 2018.
Both missions have flown spacecraft around the Earth to study changes to the planet's waters, ice sheets and solid Earth.
On average between 2002 and now, the Antarctic has lost an average of 136 gigatons per year, while Greenland is losing approximately 267 gigatons per year.
Thanks to the growth between 2021-2023, current levels in 2025 are not as low as they were in January 2021, but also not by much.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
2 days ago
- ABC News
Antarctic scientists analyse first samples from 'Million Year Ice Core' project
Inside an ice-cold laboratory in Hobart, where the temperature is almost 20 degrees Celsius below zero, scientists in thick puffer jackets begin their work. Wearing gloves, they carefully pull out a one-metre cylinder of ice from an insulated box that recently arrived from Antarctica. "In the freezer lab today, we're cutting the first samples from the 'Million Year Ice Core'," Dr Joel Pedro explained. For almost a decade, the paleoclimatologist and a team from the Australian Antarctic Program have been planning an ambitious project. Known as the 'Million Year Ice Core', the aim is to extract the world's oldest, continuous core of ice from deep beneath the frozen continent. "More than any other archive of climate in the past, [ice cores have] a range of information that helps you to understand the changes in the total climate system," Dr Pedro said. In other words, ice cores are like time capsules that allow scientists to get a clear picture of the Earth's climate and atmospheric history. That's because they contain tiny bubbles of air trapped over thousands, and even millions of years, depending on the depth of the ice. The ice that's being analysed in the Hobart laboratory comes from a depth of 150 metres, making it almost 4,000 years old. While it's a significant milestone, it's only the start of a much bigger mission. Over the coming years, the team hopes to reach a depth of 3,000m. If successful, it will be the oldest ice ever recovered. Getting to this point has been a mammoth logistical undertaking. The drill site, known as Dome C North, is 1,200 kilometres from the nearest Australian station in Antarctica. It's also 3,000m above sea level, where the temperature can fall below minus-50 degrees Celsius. Turning the site into a deep field station involved a 10-person team using six tractors to haul almost 600 tonnes of gear across the frozen landscape. "In the Australian program, it's the biggest traverse that we've undertaken," traverse leader Chris Gallagher, from the AAD, said. After enduring multiple blizzards, the team eventually made it to Dome C North 18 days after setting off from Casey Station. "It's a very specialised team that has extremely high skills, but also that ability to really get on with each other and care for each other," Mr Gallagher said. Once the accommodation modules and drill shelter were set up, a separate team of scientists flew in to begin drilling and processing the ice core. Chelsea Long, a field assistant, said the extraction of the first section of ice was a momentous occasion. "It was really celebratory when it came out and just finally to see this happening and to touch the ice and measure it, was a real joy," she said. For Dr Pedro, it was a moment to savour after many years of hard work, as well as delays caused by the COVID pandemic. "The start to the project was easily the most exciting thing that's happened in my science career," he said. "But at the same time, it's just the start of the project — we've [still] got 3 kilometres to go." Currently, the oldest ice core on record dates back almost 800,000 years. But a European team, known as Beyond EPICA, recently extracted ice from a depth of 2,800m, which is expected to date back almost 1.2 million years. The Australian team plans to drill more than 200m deeper than Beyond EPICA, which Dr Pedro said could date back up to 2 million years. "If we can get this record − and the modelling suggests [Dome C North] is the best site in Antarctica for recovering [the] oldest ice − then we'll produce data that will stand for decades as the measurement of Earth's atmosphere [and] greenhouse gas levels through that period." If successful, that data would help scientists better understand why the Earth's ice ages became much longer about a million years ago. "It remains one of the biggest puzzles, [or] challenges, in ice core science and in climate science to resolve what the cause of that was, and, in particular, what the role of C02 [carbon dioxide] was in that." Data from the 'Million Year Ice Core' could also improve the accuracy of climate change forecasts. The team plans to resume drilling during the 2025/26 summer and expect to reach the 3,000m-mark in 2028/29.
News.com.au
6 days ago
- News.com.au
Dengue surges as climate change bites but one Aussie drug trial has slapped symptoms
Dengue cases explode as climate change and urban sprawl fuel surge World scrambles as virus spreads with no easy fix Island Pharma's dengue drug cuts symptoms in Phase 2 trial There's a buzz in the air. You might not notice it at first, but it's becoming harder to ignore. It belongs to mosquitoes, and they're not just a nuisance anymore. They're carrying a virus that's spreading fast, breaking out of the tropics and catching the world off guard. Dengue fever, once considered a regional menace, has gone global. In 2023, the world recorded over 6 million cases. In 2024, they have exploded to as high as 2.8 million cases a month. So what's going on? According to Professor Zulkifli Ismail, Chairman of the Asia Dengue Voice and Action Group (ADVA), a perfect storm is brewing. 'There are a number of things that are thought to drive this increase. The most popular of which is climate change and global warming that favours the mosquito breeding habits,' he told Stockhead. Rapid urbanisation and more new construction sites also create new water collections for Aedes eggs. In addition, inadequate vector control causes an increase in the Aedes mosquito, the Professor added. 'An example is fogging that's meant to kill adult mosquitoes, but inevitably also kills frogs that feed on the mosquitoes and larvae.' People's habits also play a role. When we don't take care of the environment or delay seeing a doctor when symptoms start, it gives the virus more chances to spread. 'It's thought that almost 70% of dengue cases are asymptomatic, meaning that these are potential mosquito-bite victims that can help to transmit the virus.' Connection between climate change and dengue Dengue travels through two species of mosquitoes: Aedes aegypti and Aedes albopictus, who act like little flying syringes. These insects are cold-blooded, which means their biology speeds up with heat. Climate change is therefore making conditions more ideal for them. Warmer temperatures are helping them breed faster, live longer, and spread into regions that were once too cold for outbreaks to take hold. A recent study spanning 21 countries found that climate change alone is responsible for about 20% of dengue's rise from 1995 to 2014. And that's in regions where dengue was already endemic, like Brazil, Indonesia and India. The outlook is worse for parts of the world that are just now entering mosquito-friendly territory. 'There are certain 'hot spot' areas and these are related to the density of the Aedes aegypti and, to an extent, the Aedes albopictus mosquitoes that can transfer the virus from one person to another,' said Professor Ismail. And then there's the world's urban sprawl where rubbish builds up. That, plus global travel, is a recipe for outbreaks. Not just 'breakbone fever' Dengue earned the nickname 'breakbone fever' because of the intense muscle and joint pain it can cause, which makes you feel like your bones are cracking. In severe cases, dengue can lead to internal bleeding, low platelet counts, and even organ failure. It can also affect the nervous system, causing conditions like encephalitis or Guillain-Barré syndrome. There are four types of the virus, so getting dengue once doesn't mean you're safe. Repeat infections can be worse. And there's still no widely available treatment. Supportive care and fluids are the standard. Vaccines exist, but they're complex and not easy to access. Professor Ismail's group, ADVA, helps countries improve their local responses by sharing expertise and encouraging more coordinated action. Some countries, like Indonesia and Malaysia, have tried using Wolbachia-infected mosquitoes to reduce the spread of dengue. The results have been good, but the method is expensive and not easy to roll out everywhere. Hope from Australia's Island Pharma? With the virus on the march and few medical options on the table, an Aussie biotech called Island Pharmaceuticals (ASX:ILA) is starting to draw attention. Its lead candidate, ISLA-101, is a repurposed antiviral. It was originally developed for other uses, including cancer, but is now being trialled as a potential treatment and preventative for dengue fever. The drug works by stopping a key viral protein from entering the nucleus of human cells. That step is essential for the virus to replicate. If the protein can't get in, the virus can't multiply. It's a clean, targeted mechanism, and so far, it's showing signs of promise. Island recently completed its Phase 2a/b PROTECT trial in the US, using a dengue human infection model. This model is as close as possible to a real-world scenario, but within a controlled environment. Healthy volunteers were given either ISLA-101 or a placebo, then deliberately exposed to a weakened strain of dengue virus. This strain, provided by the US Army, causes mild to moderate symptoms and allows researchers to study viraemia and drug response safely. More on Island's trials The trial was split into two parts. In the preventative arm (Phase 2a), participants received ISLA-101 three days before virus exposure. The results were encouraging. Those given the drug had a clear drop in viral load and reported fewer symptoms than those on placebo. On average, the placebo group reported around 63% of all possible dengue symptoms, while those given ISLA-101 reported about 33%. This suggests the drug may help prevent or reduce the severity of infection when taken early. In the treatment arm (Phase 2b), participants were exposed to dengue first, then given ISLA-101 seven days later. There were signs the drug still had an effect on viral replication, but because some participants were already showing symptoms at the time of dosing, changes in clinical outcomes were less consistent and are still under analysis. Importantly, the trial met its key objectives. It confirmed safety, reached the target drug concentration in blood, and showed early signs of antiviral activity. The results were strong enough to warrant deeper clinical investigation. The world is watching, and waiting ... Professor Stephen Thomas, who helped oversee the trial, said the dengue problem is worsening, and the number of candidate countermeasures in clinical testing does not align with the global scope of the problem. 'For this reason, we are very excited Island's candidate compound demonstrated evidence of antiviral activity against a rigorous dengue human infection model. These results set the stage for continued clinical development.' The study also involved a strong group of collaborators, including Island, Upstate Medical University, the Walter Reed Army Institute of Research, and the US Army's Medical Research Program. With these Phase 2a/b results now in hand, Island is reviewing the data with its scientific and clinical advisors to plan the next stage. This could include a larger study and more detailed analysis of both prevention and treatment use cases. If ISLA-101 continues to show clinical benefit, it may become eligible for a Priority Review Voucher from the FDA. These vouchers allow faster approval for future drugs or can be sold to other companies, often for over US$110 million. "If antiviral can convincingly reduce the viraemia and also mitigate severe dengue, it will be one of the tools in our armamentarium to treat dengue cases," said Professor Ismail. It's still early, but in a world with millions of dengue infections each year and no widely available treatment, Island's progress is worth paying close attention to. At Stockhead we tell it like it is. While Island Pharmaceuticals is a Stockhead advertiser, it did not sponsor this article.
ABC News
7 days ago
- ABC News
Adapt or collapse – can we meet the moment of environmental peril
Do humans really have what it takes to change our lives – our world – to arrest climate collapse? It might be the defining question we face as a society, and the panellists from this WOMADelaide Festival discussion are throwing everything they've got at this intractable issue, drawing on knowledge from the oldest continuing culture in the world and the fields of architecture, urban planning and of course, community organising to avoid collapse. This episode was recorded live at the annual 2025 WOMADelaide festival, produced and presented as part of their Planet Talks program, held on the traditional lands of the Kuarna people. Speakers Bhiamie Williamson Leader of the National Indigenous Disaster Resilience research program and a senior lecturer at Monash University Elizabeth Mossop Dean of the UTS School of Design, Architecture and Building Emma Bacon Founder and Executive Director of Sweltering Cities Julia Lester Former ABC journalist and broadcaster (host)
